Professor of Pediatrics and Director, Laboratory of Biochemical Pharmacology at Emory University
Dr. Raymond F. Schinazi is the Frances Winship Walters Professor of Pediatrics and Director of the Laboratory of Biochemical Pharmacology at Emory University and co-Director of the HIV Cure Scientific Working Group for the NIH-sponsored Emory University Center for AIDS Research (CFAR). He has authored over 550 peer-reviewed papers and 7 books and holds over 100 issued US patents, which have resulted in 15 New Drug Applications (NDA). A world leader in nucleoside chemistry, Dr. Schinazi is best known for his pioneering work on HIV, HBV and HCV drugs d4T (stavudine), 3TC (lamivudine), FTC (emtricitabine), LdT (telbivudine), and sofosbuvir (Sovaldi), which are all approved by the US FDA. More than 94% of HIV-infected individuals in the US on combination therapy take at least one of the drugs he invented. Dr. Schinazi served on the Presidential Commission on AIDS. He is the recipient of numerous awards including the 2015 William S. Middleton Award from the Department of Veterans Affairs, which is the highest honor for outstanding achievement in biomedical research. He is also the recipient of the 2016 Institute of Human Virology’s Lifetime Achievement Award for Public Service and 2016 Scrip Lifetime Achievement Award. Dr. Schinazi is internationally recognized as one of the most influential persons in the life science sector.